Skip to main content

Table 1 Baseline demographic, anthropometric and clinical data of episodic migraine patients in a randomized controlled trial of vitamin D vs. placebo

From: The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial

 

Vitamin D (n = 40)

Placebo (n = 40)

P value#

Age (year)

37 (8)

38 (12)

0.819

Headache Onset years (year)

12 (8)

11 (8)

0.679

Body mass index (kg/m2)

25.83 (4.07)

25.36 (4.29)

0.613

Sex

 Female

32 (80.0%)

32 (80.0%)

1.000

 Male

8 (20.0%)

8 (20.0%)

Marital Status

 Married

31 (77.5%)

26 (65.0%)

0.339

 Single

9 (22.5%)

13 (32.5%)

 Widow/widower

0 (0%)

1 (2.5%)

Educational Status

 High school

13 (32.5%)

16 (40.0%)

0.293

 BSc

11 (27.5%)

7 (17.5%)

 MS

8 (20.0%)

13 (32.5%)

 PhD and higher

8 (20.0%)

4 (10.0%)

Job

 No job/house wife

12 (30.0%)

16 (40.0%)

0.480

 Student

1 (2.5%)

3 (7.5%)

 Employee

23 (57.5%)

17 (42.5%)

 Self employed

4 (10.0%)

4 (10.0%)

Migraine Aura

 Migraine with aura

13 (32.5%)

10 (25.0%)

0.459

 Migraine without aura

27 (67.5%)

30 (75.0%)

Familial History of Migraine

 Yes

26 (65.0%)

32 (80.0%)

0.133

 No

14 (35.0%)

8 (20.0%)

Smoking Status

 No

37 (92.5%)

35 (87.5%)

0.549

 Yes

0 (0%)

1 (2.5%)

 More than 5 cigarette per week

3 (7.5%)

4 (10.0%)

 Less than 5 cigarette per week

0 (.0%)

0 (0%)

  1. Values are expressed as mean (SD) or number (%) as appropriate
  2. #Using either Independent t test or Chi square according to the type of data